NLGIA
DPLO

Nippon Life Global Investors Americas’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Nippon Life Global Investors Americas’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-70,220
Closed -$1.92M – 139
2016
Q1 		$1.92M Sell
70,220
-10,840
-13% -$319K 0.18% 114
2015
Q4 		$2.77M Buy
+81,060
New +$2.53M 0.26% 104

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Nippon Life Global Investors Americas's DPLO Position: Q2 2016 in Review

Nippon Life Global Investors Americas sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2016, closing a stake of 70,220 shares — an estimated $1.92M sold.

Nippon Life Global Investors Americas first reported a position in DPLO in Q4 2015 and held it in 2 quarters. The position peaked at $2.77M in Q4 2015. 166 funds tracked by Wall St. Rank hold DPLO as of Q2 2016.

  • Nippon Life Global Investors Americas reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2016 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 70,220 DIPLOMAT PHARMACY, INC. shares in Q2 2016, an estimated $1.92M.
  • Nippon Life Global Investors Americas first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 2 quarters.
  • Nippon Life Global Investors Americas's DIPLOMAT PHARMACY, INC. position peaked at $2.77M in Q4 2015.
  • 166 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2016.

Based on Nippon Life Global Investors Americas's 13F filing for Q2 2016, filed 9 Aug 2016.